Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Ocrelizumab may cause pancreatitis in some patients.

Abatacept may help some people with alopecia areata regrow hair.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Belimumab may cause hair loss in lupus patients.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Dupilumab effectively treated severe alopecia areata in a child.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Enhancing Tregs can protect against alopecia areata.